Nautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Nautilus Biotechnology(US:NAUT) Seeking Alphaยท2025-09-08 20:57Company Overview - Nautilus is positioned within the evolving proteomics landscape, offering a unique approach compared to existing platforms [2]. Competitive Landscape - Nautilus differentiates itself from other proteomics platforms, including proteomic sequencing companies like QSI and Encodia, targeted proteomics platforms such as Olink or SomaLogic, nanopore protein sequencing, and protein fingerprinting [2].